Buckeye Pause Bundle
Public ClinicalTrials.gov record NCT07720297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Buckeye Pause Bundle: Augmenting State of Mind and Body as the Ultimate Personal Protective Equipment (PPE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Mind-body resilience is particularly important in workplaces where there are frequent exposures to primary or secondary emotional and/or physical trauma. A 2020 report from the U.S. Bureau of Labor Statistics highlighted health workers as among the largest service industries in the state of Ohio with the most amount of missed work days due to injury or illness. The purpose of this study is to develop and establish proof-of-concept of the "Buckeye Pause Bundle," a proactive workplace facilitation of mind-body resilience protective and recovery activities that includes an evidence-based mindfulness-based intervention, a wearable health device that offers user prompts and reminders based on physiological data, and worksite respite pods to support brief mindfulness practices during the workday. The target market segment for this proof-of-concept testing is healthcare providers working in acute care hospital settings. It is anticipated that end prototypes and deliverables will be very transferable to other high-stress work environments.
Study identification
- NCT ID
- NCT07720297
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 220 participants
Conditions and interventions
Interventions
- Augmented Mindfulness-based Intervention Behavioral
- Mindfulness-based intervention Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 11, 2022
- Primary completion
- May 31, 2023
- Completion
- May 31, 2024
- Last update posted
- Jul 21, 2026
2022 – 2024
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07720297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07720297 live on ClinicalTrials.gov.